Cargando…

HMGB2 regulates the differentiation and stemness of exhausted CD8(+) T cells during chronic viral infection and cancer

Chronic infections and cancers evade the host immune system through mechanisms that induce T cell exhaustion. The heterogeneity within the exhausted CD8(+) T cell pool has revealed the importance of stem-like progenitor (Tpex) and terminal (Tex) exhausted T cells, although the mechanisms underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: Neubert, Emily N., DeRogatis, Julia M., Lewis, Sloan A., Viramontes, Karla M., Ortega, Pedro, Henriquez, Monique L., Buisson, Rémi, Messaoudi, Ilhem, Tinoco, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499904/
https://www.ncbi.nlm.nih.gov/pubmed/37704621
http://dx.doi.org/10.1038/s41467-023-41352-0
Descripción
Sumario:Chronic infections and cancers evade the host immune system through mechanisms that induce T cell exhaustion. The heterogeneity within the exhausted CD8(+) T cell pool has revealed the importance of stem-like progenitor (Tpex) and terminal (Tex) exhausted T cells, although the mechanisms underlying their development are not fully known. Here we report High Mobility Group Box 2 (HMGB2) protein expression is upregulated and sustained in exhausted CD8(+) T cells, and HMGB2 expression is critical for their differentiation. Through epigenetic and transcriptional programming, we identify HMGB2 as a cell-intrinsic regulator of the differentiation and maintenance of Tpex cells during chronic viral infection and in tumors. Despite Hmgb2(−/−) CD8(+) T cells expressing TCF-1 and TOX, these master regulators were unable to sustain Tpex differentiation and long-term survival during persistent antigen. Furthermore, HMGB2 also had a cell-intrinsic function in the differentiation and function of memory CD8(+) T cells after acute viral infection. Our findings show that HMGB2 is a key regulator of CD8(+) T cells and may be an important molecular target for future T cell-based immunotherapies.